Comment on aminoglycoside evaluation.
D000617:Aminoglycosides / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents